KRISTINA KARAPETYAN: Open Payments
NPI 1598829434 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 34 payments from 17 companies in 2025. Trend: 2023 $453 · 2024 $661 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 7 | $151 |
| ABBVIE INC. | 5 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $117 |
| PFIZER INC. | 4 | $99 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Ardelyx, Inc. | 2 | $54 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Dexcom, Inc. | 1 | $38 |
| Lilly USA, LLC | 1 | $33 |
Products named: ACCRUFER, AIRSUPRA, QULIPTA, DUPIXENT, NURTEC ODT, IBSRELA, ZENPEP, ELIQUIS.
Industry payments across CA — which companies pay providers there.
